84763-015 HEAD LICE TREATMENT IVERMECTIN LOTION

Manufacturer
Yunqi Cosmetics (Shenzhen) Co., Ltd
Effective date
2026-07-15
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-07-18 05:11:05

Label at a glance#

ProductHead Lice Treatment Ivermectin Lotion118mL
Active ingredientIVERMECTIN
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Ivermectin 0.5%

OTC - PURPOSE SECTION

Lice treatment

INDICATIONS & USAGE SECTION

Treats head lice.

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use on broken or severely irritated skin.

OTC - WHEN USING SECTION


When using this product
Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
Use only on the scalp and hair.

keep eyes tightly closed and protect eyes with a washcloth or towel
if product gets into eyes, gently flush with water eye redness, soreness, or irritation can occur
dandruff, dry skin, or burning sensation of the skin can occur
use only on scalp and hair

OTC - STOP USE SECTION


Stop use and ask a doctor if
Skin irritation, redness, or rash develops and persists.
Signs of an allergic reaction occur.
Head lice remain after treatment or symptoms worsen.


breathing difficulty occurs
eye irritation occurs
skin or scalp irritation continues or infection occurs rash develops

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

OTC - ASK DOCTOR/PHARMACIST SECTION

have any skin conditions or sensitivities

are pregnant or plan to become pregnant

are currently or planning to breastfeed

DOSAGE & ADMINISTRATION SECTION

Children 6 months to under 12 years of age: Adult supervision is required.
Adults and children 6 months of age and over:
hair and scalp must be dry before applying product apply enough lotion to completely cover dry hair and scalp

completely cover the scalp and hair closest to the scalp first, then apply outward toward the ends of the hair rub product throughout hair
leave on hair and scalp for 10 minutes after hair and scalp are completely covered
after 10 minutes, rinse product completely from hair and scalp using only water
after rinsing, dry and style hair as usual

wait 24 hours before applying shampoo
nit combing is not necessary for treatment to work, but a fine-tooth comb may be used to remove dead lice and nits if desired
do not use again on the same person and same lice infestation without talking to a healthcare provider first if infestation continues, see a doctor for other treatments

INACTIVE INGREDIENT SECTION

Water
Caprylic/Capric Triglyceride
Glycerin
Cetearyl Alcohol
Glyceryl Stearate
PEG-100 Stearate
Cetyl Alcohol
Dimethicone
Panthenol
Allantoin
Aloe Barbadensis Leaf Juice
Tocopherol
Carbomer
Disodium EDTA
Phenoxyethanol
Ethylhexylglycerin

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label3label3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84763-01584763-015-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Head Lice Treatment Ivermectin Lotion118mLIVERMECTINYunqi Cosmetics (Shenzhen) Co., Ltd56a37d8f-c1b8-465a-e063-6394a90aa3342026-07-15WarningsExact identifier
ndc (package): 84763-015-01
ndc (product): 84763-015
ndc11 (package): 84763001501
spl id: 56a37d8f-c1b9-465a-e063-6394a90aa334
spl set id: 56a37d8f-c1b8-465a-e063-6394a90aa334

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.